FDA Adverse Event Injury Summary report: N

LOGIC TIB INSERT IMPL CRC, SZ 4, 11MM

MDR report key: 15537129 · Received October 4, 2022

Report

Report Number
1038671-2022-01234
Event Type
Injury
Date Received
October 4, 2022
Date of Event
September 12, 2022
Report Date
December 31, 2025
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862230492
PMA / PMN Number
K123342
Removal / Correction Number
Z-0021-2022
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PENDING EVALUATION. CONCOMITANT DEVICE(S): 02-010-04-0340 - LOGIC CR FEMORAL POR, RIGHT, SZ 4 4719880, 02-012-45-4050 - LGC TIBIAL FIT TRAY CEM SZ 4F / 5T 6029557, 200-02-41 - THREE PEG PATELLA 41MM 4481559,

Additional Manufacturer Narrative · 0

SECTION H10: (H3) THE REVISION REPORTED WAS MOST LIKELY THE RESULT OF PROSTHESIS WEAR INITIATED BY UNINTENDED CONTACT BETWEEN INCONGRUENT SURFACES OF THE TIBIAL INSERT AND FEMORAL COMPONENT. HOWEVER, CONTRIBUTIONS FROM INSTABILITY OF THE KNEE JOINT, COMPONENT ALIGNMENT, AND/OR PATIENT-CONDITIONS TO THE SEQUENCE OF EVENTS CANNOT BE DETERMINED FROM THE REPORTED CLINICAL INFORMATION. HAVING BEEN PACKAGED IN A NON-CONFORMING VACUUM BAG FOR MORE THAN FIVE YEARS MAY ALSO HAVE BEEN CONTRIBUTING FACTOR TO THE EXTENT OF WEAR NOTED ON THE TIBIAL INSERT. THE FOLLOWING SECTIONS HAVE CORRECTED INFORMATION: (H6) COMPONENT CODE: 734, BEARINGS.

Description of Event or Problem · 0

AS REPORTED, APPROXIMATELY 1.5 YEARS POST OP THE INITIAL RIGHT TKA, THIS FEMALE PATIENT WAS REVISED DUE TO A SWOLLEN KNEE AND PAIN CAUSED DUE TO POLY WEAR FROM THE BAD BATCH OF POLY. INSERT AND PATELLA CHANGED. PATIENT REVISED TO EXACTECH DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2506688 LOGIC TIB INSERT IMPL CRC, SZ 4, 11MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL JWH EXACTECH, INC. 02-012-51-4011 UNK 10885862230492

Patients

Seq Age Sex Outcome Treatment
1 NA Female Hospitalization| R SEE H10.